- Issuer ticker
-
GTBP
- Reported as of
-
11 Aug 2023
- Net transaction value
-
+$57,400
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
15 Aug 2023, 19:26:31 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Manu Ohri
Key filing fact
Manu Ohri filed Form 4 for GT Biopharma, Inc. (GTBP) on 15 Aug 2023.
Key facts
- This page summarizes Manu Ohri's Form 4 filing for GT Biopharma, Inc. (GTBP).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Aug 2023, 19:26.
Change
- Previous filing in this sequence was filed on 10 Apr 2023.
- Current net transaction value: +$57,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GTBP
transaction
Common Stock
Award
- Transaction value
- $57,400
- Shares
- +200,000
- Change %
- Price
-
$0.2870
- Shares after
- 200,000
- Date
- 11 Aug 2023
- Ownership
- Direct
GTBP
transaction
Common Stock
Other
- Transaction value
- $57,400
- Shares
- -200,000
- Change %
- -100%
- Price
-
$0.2870
- Shares after
- 0
- Date
- 11 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
GTBP
transaction
Common Stock
Other
- Transaction value
- $57,400
- Shares
- +200,000
- Change %
- +200%
- Price
-
$0.2870
- Shares after
- 300,000
- Date
- 11 Aug 2023
- Ownership
- By Anarjay Concepts, Inc.
- Footnotes
- F1
GTBP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 50,000
- Date
- 11 Aug 2023
- Ownership
- By Ohri Family Revocable Trust U/A Dated 02/10/2020
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote